PSC
ETRM

Piper Sandler & Co’s EnteroMedics Inc. ETRM Stock Holding History

Piper Sandler & Co’s Portfolio ETRM Stock Details ETRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-142
Closed -$303K – 155
2013
Q4 		$303K Buy
+142
New +$229K 0.25% 57

Other funds holding ETRM

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IHM
Iguana Healthcare Management New York $152M AUM 48.74% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
WPC
White Pine Capital Bloomington, Minnesota $355M AUM 45.63% 1-Year Est. Return

Piper Sandler & Co's ETRM Position: Q1 2014 in Review

Piper Sandler & Co sold out of EnteroMedics Inc. (ETRM) in Q1 2014, closing a stake of 142 shares — an estimated $303K sold.

Piper Sandler & Co first reported a position in ETRM in Q4 2013 and held it in 1 quarter. The position peaked at $303K in Q4 2013. 57 funds tracked by Wall St. Rank hold ETRM as of Q1 2014.

  • Piper Sandler & Co reported no remaining EnteroMedics Inc. position as of Q1 2014 after selling out during the quarter.
  • Piper Sandler & Co sold 142 EnteroMedics Inc. shares in Q1 2014, an estimated $303K.
  • Piper Sandler & Co first reported a position in EnteroMedics Inc. in Q4 2013 and held it in 1 quarter.
  • Piper Sandler & Co's EnteroMedics Inc. position peaked at $303K in Q4 2013.
  • 57 funds tracked by Wall St. Rank held EnteroMedics Inc. as of Q1 2014.

Based on Piper Sandler & Co's 13F filing for Q1 2014, filed 15 May 2014.